Celularity (CELU) EBIT (QoQ) (2019 - 2025)
Celularity (CELU) EBIT (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Celularity | 20.90 Mn | 14.72 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -70.99% |
| Sep 30, 2025 | 18.68% |
| Jun 30, 2025 | -51.29% |
| Mar 31, 2025 | -13.00% |
| Dec 31, 2024 | 19.49% |
| Sep 30, 2024 | -13.29% |
| Jun 30, 2024 | -37.95% |
| Mar 31, 2024 | -155.40% |
| Dec 31, 2023 | 113.41% |
| Sep 30, 2023 | -133.68% |
| Jun 30, 2023 | 33.50% |
| Mar 31, 2023 | -465.28% |
| Dec 31, 2022 | 409.69% |
| Sep 30, 2022 | -235.23% |
| Jun 30, 2022 | 110.03% |
| Mar 31, 2022 | -178.34% |
| Dec 31, 2021 | -237.19% |
| Sep 30, 2021 | 117.98% |
| Jun 30, 2021 | -36.53% |
| Mar 31, 2021 | -501.58% |